Meeting
2022 ASCO Annual Meeting
Effect of more versus less frequent abdominopelvic computed tomography follow-up testing on overall survival in patients with stage II or III colon cancer.
Authors
Jeon Jeongseok
Yonsei University, College of Medicine, Seoul, South Korea
Jeon Jeongseok , Da Bin Lee , Seung-Hoon Beom , Sang Joon Shin , Joong Bae Ahn , Han Sang Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer - Neo-Adjuvant/Adjuvant
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 3604)
DOI
10.1200/JCO.2022.40.16_suppl.3604
Abstract #
3604
Poster Bd #
398
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
The number of lymph nodes examined as a poor prognosis factor in stage II and stage III colon cancer patients undergoing curative surgery.
First Author: JEONGSEOK JEON
First Author: Lucy Gately
Poster
2019 Gastrointestinal Cancers Symposium
Evaluating the prognostic significance of lymphovascular invasion in stage II and III colon cancer.
First Author: Dorotea Mutabdzic
Poster
2018 ASCO Annual Meeting
CD3+ and CD8+ tumor-infiltrating lymphocyte (TIL) densities to prognostically stratify DNA mismatch repair-deficient (dMMR) colon cancer patients (pts): NCCTG N0147 (Alliance).
First Author: Harry H. Yoon